Prolonged efficacy of islet neogenesis therapy methods with a gastrin/CCK receptor ligand and an EGF receptor ligand composition in subjects with preexisting diabetes

Details for Australian Patent Application No. 2008201347 (hide)

International Classifications

Event Publications

17 April 2008 Complete Application Filed

24 April 2008 Section 223 Application Allowed

Not Given The time in which to make a further application for a divisional patent has been extended to 22 Mar 2008. Address for service in Australia - Davies Collison Cave Level 3 303 Coronation Drive Milton QLD 4064

24 April 2008 Application Open to Public Inspection

Published as AU-A-2008201347

20 November 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.